Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The keratin layer of the epidermis, most specifically the stratum corneum, is the outermost barrier protecting the body from dehydration, infection, toxins, and physical injury[1][3][4]. It consists mainly of keratinocytes filled with keratin, a tough, fibrous protein that imparts water resistance and durability[1][2][3][5][7]. Keratinocytes originate in the basal epidermal layer, mature as they rise, and eventually die, leaving behind their keratin-rich remnants in the stratum corneum[1][3][5][6]. While not a single molecular target, this layer is a functional target in dermatology (e.g., drug delivery, barrier repair, diseases of hyperkeratosis)[3][8]. In drug development or clinical testing, the keratin layer is referenced primarily as a barrier, not as a molecular receptor, making the query technically incorrect for most therapeutic target databases.
Restore/maintain barrier integrity - Promote cell turnover (keratolytics) - Reduce inflammation (corticosteroids, immunomodulators) - Modulate keratinocyte differentiation (retinoids)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin layer of epidermis (none).